Close

UCB Wins Customer Innovation and Lifetime Value Achievement Awards for Improving Patient Experience

Related stories

hubXchange Announces Upcoming Series of Exclusive Roundtable Events in San Diego – February 2025

hubXchange, the premier platform for senior-level knowledge exchange in...

Aragen receives Platinum Medal from EcoVadis for its sustainability initiatives

Hyderabad: Aragen Life Sciences, a globally renowned Contract Research,...

Danish protein analysis to revolutionize the biopharma industry’s impurity control

The requirements for quality assurance of biologics are increasing....

Berry Global Healthcare to Showcase New Packaging Innovations at Pharmapack 2025

Berry Global Healthcare, a leader in innovative packaging solutions,...

Two of UCB’s biggest patient innovators were announced as winners at the eyeforpharma Barcelona Awards for their long-term commitment to improve patient experiences.

Christi Marsh, Director of North American Medical Information and Communications and responsible for UCBCares, as well as departing CEO Roch Doliveux were commended for innovation and focus on the needs of patients.

Marsh won the Customer Innovator Award, while Doliveux joined Patrick Cashman of Lundbeck Canada as the second ever winner of the Lifetime Value Achievement Award.

UCBCares, which combines all call-centres and sources of patient and customer services under one number and office, was commended by 2014 winner of the Customer Innovator Award, John Pugh from Boehringer Ingelheim.

Patients are assigned a solutions manager to personally address their concerns from assistance, medical information and healthcare referrals to clinical study guidance and even non-UCB medication.

Nominated for the Lifetime Value Achievement Award for the second year in a row, Mr Doliveux is now recognised for developing UCB into a focused, patient-centric industry leader recognised for growth and a strong pipeline.

In 2012, Mr Doliveux unveiled UCB’s new tagline ‘Inspired by patients. Driven by science.’

The focus on empathy and innovation reflects the core of what UCB has become under Mr Doliveux’s leadership, with the company annually surveying all 9,000 staff to determine the level of patient-centric employee attitudes.

The awards both befit a consistent and determined approach to innovation, resilience and value creation over many years.

eyeforpharma chairman Paul Simms said: “Roch is very deserving of this award, showing that true innovation and patient-centricity in pharma should be driven right from the top of the business.

“His approach combines successful business with what truly matters in pharma: improving the lives of others.”

 

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories